APOLLO MEDICAL HOLDINGS INC (AMEH)
US03763A2078 - Common Stock
Overall AMEH gets a fundamental rating of 7 out of 10. We evaluated AMEH against 117 industry peers in the Health Care Providers & Services industry. AMEH gets an excellent profitability rating and is at the same time showing great financial health properties. AMEH is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make AMEH suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
AMEH had positive earnings in the past year.
In the past year AMEH had a positive cash flow from operations.
AMEH had positive earnings in each of the past 5 years.
In the past 5 years AMEH always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.27%, AMEH is doing good in the industry, outperforming 74.58% of the companies in the same industry.
AMEH has a Return On Equity of 7.71%. This is in the better half of the industry: AMEH outperforms 71.19% of its industry peers.
AMEH has a Return On Invested Capital of 7.06%. This is in the better half of the industry: AMEH outperforms 75.42% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMEH is in line with the industry average of 8.61%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROIC | 7.06% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
1.3 Margins
Looking at the Profit Margin, with a value of 3.45%, AMEH is in the better half of the industry, outperforming 75.42% of the companies in the same industry.
AMEH's Profit Margin has improved in the last couple of years.
AMEH's Operating Margin of 7.61% is fine compared to the rest of the industry. AMEH outperforms 77.97% of its industry peers.
AMEH's Operating Margin has improved in the last couple of years.
AMEH's Gross Margin of 16.34% is on the low side compared to the rest of the industry. AMEH is outperformed by 70.34% of its industry peers.
In the last couple of years the Gross Margin of AMEH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% |
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
AMEH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AMEH has more shares outstanding
Compared to 5 years ago, AMEH has more shares outstanding
Compared to 1 year ago, AMEH has an improved debt to assets ratio.
2.2 Solvency
AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
AMEH's Altman-Z score of 4.53 is amongst the best of the industry. AMEH outperforms 83.90% of its industry peers.
AMEH has a debt to FCF ratio of 1.89. This is a very positive value and a sign of high solvency as it would only need 1.89 years to pay back of all of its debts.
The Debt to FCF ratio of AMEH (1.89) is better than 85.59% of its industry peers.
AMEH has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
AMEH's Debt to Equity ratio of 0.35 is fine compared to the rest of the industry. AMEH outperforms 65.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.85
WACC8.27%
2.3 Liquidity
A Current Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
The Current ratio of AMEH (2.35) is better than 79.66% of its industry peers.
AMEH has a Quick Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AMEH (2.35) is better than 81.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
AMEH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 42.03% yearly.
Looking at the last year, AMEH shows a very strong growth in Revenue. The Revenue has grown by 27.05%.
The Revenue has been growing by 81.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS growth Q2Q-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Revenue growth Q2Q9.84%
3.2 Future
The Earnings Per Share is expected to grow by 15.59% on average over the next years. This is quite good.
The Revenue is expected to grow by 26.59% on average over the next years. This is a very strong growth
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.82 indicates a quite expensive valuation of AMEH.
Based on the Price/Earnings ratio, AMEH is valued a bit cheaper than 60.17% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.06, AMEH is valued a bit more expensive.
AMEH is valuated quite expensively with a Price/Forward Earnings ratio of 28.34.
62.71% of the companies in the same industry are more expensive than AMEH, based on the Price/Forward Earnings ratio.
AMEH's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 20.72.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
AMEH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 61.86% of the companies in the same industry.
AMEH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 73.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.06 | ||
| EV/EBITDA | 15.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AMEH has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as AMEH's earnings are expected to grow with 15.59% in the coming years.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%
5. Dividend
5.1 Amount
No dividends for AMEH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APOLLO MEDICAL HOLDINGS INC
NASDAQ:AMEH (2/23/2024, 7:00:00 PM)
After market: 40.82 0 (0%)40.82
-0.88 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.90B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.64
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5Y
EPS growth Q2Q
EPS Next Y15.47%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y